PGRMC1 Elevation in Multiple Cancers and Essential Role in Stem Cell Survival

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Cancer remains a leading cause of death, necessitating novel therapeutic strategies.
• Progesterone receptor membrane component 1 (PGRMC1), a heme-binding protein, is implicated in tumor progression, invasion, and metastasis.
• PGRMC1 is upregulated in multiple tumor types, including breast, colon, lung, and thyroid cancers.

Purpose of the Study:

• To analyze PGRMC1 expression levels in a large cohort of tumor sections, including oral cavity and ovarian cancers.
• To investigate the clinical significance of PGRMC1 expression in relation to patient survival.
• To evaluate the role of PGRMC1 in cancer stem cell viability and drug resistance.

Main Methods:

• Quantitative analysis of PGRMC1 protein levels in over 600 human tumor and non-malignant tissue sections.
• Clinical correlation analysis of PGRMC1 expression with patient survival data.
• In vitro studies using cancer stem cells treated with PGRMC1 inhibitors and other targeted therapies.

Main Results:

• PGRMC1 was highly expressed in lung and ovarian cancers, with expression levels correlating with patient survival.
• PGRMC1 was detected in lung tumor-derived stem cells, suggesting its role in cancer stem cell populations.
• Inhibition of PGRMC1 using AG-205 led to cancer stem cell death, unlike other tested inhibitors.

Conclusions:

• PGRMC1 serves as a potential pan-cancer biomarker, indicating its diagnostic and prognostic value.
• PGRMC1 is a critical factor in the viability of cancer stem cells.
• Targeting PGRMC1 represents a promising therapeutic strategy for overcoming drug resistance and improving cancer treatment outcomes.